Gene: BCAP31
Official Full Name: B cell receptor associated protein 31provided by HGNC
Gene Summary: This gene encodes a member of the B-cell receptor associated protein 31 superfamily. The encoded protein is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in caspase 8-mediated apoptosis. Microdeletions in this gene are associated with contiguous ABCD1/DXS1375E deletion syndrome (CADDS), a neonatal disorder. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 16. [provided by RefSeq, Jan 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05422 | BCAP31 Knockout cell line (HeLa) | Human | BCAP31 | 1:3~1:6 | Negative | Online Inquiry |
KO05423 | BCAP31 Knockout cell line (HCT 116) | Human | BCAP31 | 1:2~1:4 | Negative | Online Inquiry |
KO05424 | BCAP31 Knockout cell line (HEK293) | Human | BCAP31 | 1:3~1:6 | Negative | Online Inquiry |
KO05425 | BCAP31 Knockout cell line (A549) | Human | BCAP31 | 1:3~1:4 | Negative | Online Inquiry |
BCAP31 Gene Knockout Cell Lines are a cutting-edge biological tool designed to facilitate the study of the BCAP31 gene and its associated pathways. BCAP31, a protein involved in various cellular processes, plays a crucial role in regulating apoptosis, protein transport, and signal transduction. By employing CRISPR/Cas9 technology, these knockout cell lines have been engineered to provide researchers with a reliable system to investigate the functional consequences of BCAP31 loss, thereby elucidating its precise biological roles.
The key mechanism behind the utility of BCAP31 Gene Knockout Cell Lines lies in their ability to enable targeted gene disruption. This allows for the assessment of cellular responses to the absence of BCAP31, facilitating in-depth studies of its involvement in diseases such as cancer and neurodegenerative disorders. Researchers can use these cell lines to analyze downstream signaling pathways, gene expression changes, and cellular phenotypes, providing insights that are critical for the development of targeted therapies.
In research and clinical settings, the BCAP31 knockout model offers advantageous applications, including drug screening and biomarker discovery. Compared to traditional cell lines, the knockout model provides a more physiologically relevant platform that captures the genetic variability present in human disease states. This is particularly valuable for understanding complex disease mechanisms, allowing for the investigation of gene-environment interactions and the identification of novel therapeutic targets.
The unique selling points of these knockout cell lines include their high specificity, reproducibility, and user-friendly design, which simplifies the process of studying gene function. Moreover, they are supported by comprehensive technical documentation and user assistance, ensuring researchers can maximize their experimental outcomes.
Investing in BCAP31 Gene Knockout Cell Lines empowers researchers and clinicians to advance their studies in molecular biology and drug development. As a leader in the field of biological products, our company leverages years of expertise and innovation to provide high-quality reagents and tools essential for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.